These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27718447)

  • 1. Targeting B cells in treatment of autoimmunity.
    Franks SE; Getahun A; Hogarth PM; Cambier JC
    Curr Opin Immunol; 2016 Dec; 43():39-45. PubMed ID: 27718447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases.
    Pers YM; Jorgensen C
    Immunotherapy; 2016 Sep; 8(9):1091-6. PubMed ID: 27485081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.
    Musette P; Bouaziz JD
    Front Immunol; 2018; 9():622. PubMed ID: 29706952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell targeted therapy in autoimmunity.
    Blank M; Shoenfeld Y
    J Autoimmun; 2007; 28(2-3):62-8. PubMed ID: 17391915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab immunotherapy in pemphigus: therapeutic effects beyond B-cell depletion.
    Zambruno G; Borradori L
    J Invest Dermatol; 2008 Dec; 128(12):2745-7. PubMed ID: 18997839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis.
    Dörner T; Isenberg D; Jayne D; Wiendl H; Zillikens D; Burmester G;
    Autoimmun Rev; 2009 Dec; 9(2):82-9. PubMed ID: 19716441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
    Guzman Moreno R
    Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell immunobiology in disease: evolving concepts from the clinic.
    Martin F; Chan AC
    Annu Rev Immunol; 2006; 24():467-96. PubMed ID: 16551256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [B lymphocyte].
    Hasegawa M
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Oct; 28(5):300-8. PubMed ID: 16276043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell-ablative therapy: where are we now?
    Bordron A; Mankaï A; Bendaoud B; Saraux A; Devauchelle V; Ghedira I; Jamin C; Pers JC; Berthou C; Youinou P
    Int J Immunopathol Pharmacol; 2007; 20(4):655-9. PubMed ID: 18179738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
    Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
    J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method.
    Khademi F; Mostafaie A; Parvaneh S; Gholami Rad F; Mohammadi P; Bahrami G
    Int Immunopharmacol; 2017 Feb; 43():23-32. PubMed ID: 27939822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating human autoimmune disease by depleting B cells.
    Looney RJ
    Ann Rheum Dis; 2002 Oct; 61(10):863-6. PubMed ID: 12228152
    [No Abstract]   [Full Text] [Related]  

  • 15. The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE.
    Wang C; Pan HF; Ye DQ
    Autoimmun Rev; 2012 Mar; 11(5):373. PubMed ID: 21224014
    [No Abstract]   [Full Text] [Related]  

  • 16. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD20-mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives.
    Crickx E; Weill JC; Reynaud CA; Mahévas M
    Kidney Int; 2020 May; 97(5):885-893. PubMed ID: 32229095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of anti-CD20 "what do B-cells do?".
    Eisenberg R; Looney RJ
    Clin Immunol; 2005 Dec; 117(3):207-13. PubMed ID: 16169773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell immunotherapy in autoimmunity--2010 update.
    Chan AC
    Mol Immunol; 2011 Jun; 48(11):1344-7. PubMed ID: 21194752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.
    Ahmed AR; Kaveri S
    Front Immunol; 2018; 9():1189. PubMed ID: 30072982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.